Biocon’s Target Factory

South Korea’s 8-year effort to create an integrated platform for novel target and lead development provides an academic drug discovery model for other emerging economies.

Innovative drug discovery and development remains a profound, decades-long challenge even in established US biotech centers such as Boston and San Francisco. In many other places in the world, key facets of the drug discovery ecosystem are often missing or suboptimal. South Korea is no different. Although it has a growing biotech-services and biosimilar sector, robust companies capable of sustaining innovative therapeutic development programs remain rare. The challenge of building a national infrastructure or companies with critical mass capable of carrying out novel target discovery and lead development prompted the South Korean government to create the Medicinal Bioconvergence Research Center (Biocon) in 2010.

In this article, we describe the center’s inception, outline its main principles and strategy, provide a status update on its pipeline of products, and discuss how its principles may be relevant in other regions lacking similar requisite expertise and resources for innovative drug discovery and development.

Article Site:

Original Document:

Related Post

An article about Drug repositioning utilizing Phar...
views 867
The article about Drug repositioning using the medicine data based PharmDB, which is built by Biocon, i-Pharm, and KOBIC got an approval to be publish...
바이오콘·서린 바이오아트 경진대회 성황리에 접수 마감...
views 491
지난 7월부터 9월까지 3개월간 진행된 '2013 바이오아트 경진대회' 가 성황리에 마감되었습니다.생명과 생명현상의 아름다움에 대한 많은 관심과 성원으로 총 255점의 작품이 접수되었습니다.사진, 영상, 그림, 제작물 등 다양한 표현방법이 가능했던 만큼, 참가자들의 열...
(재)의약바이오컨버젼스연구단 연구원 채용 공고...
views 984
과학기술정보통신부는 기존 기술의 한계를 돌파하는 세계최고의 원천기술 개발을 목표로 ‘글로벌프런티어사업’을 추진하고 있으며, 본 사업의 한 분야인 ‘혁신형 의약바이오컨버젼스’를 (재)의약바이오컨버젼스연구단에서 수행 중에 있습니다. 이와 관련하여 위 연구를 통해 신약...


We're not around right now. But you can send us an email and we'll get back to you, asap.


©2010-2019 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar